- Mepaco - : [1] WebMD.com
Hankosky, PhD, senior director of Cardiometabolic Health, Health Economics and Outcomes Research at Eli Lilly & Company, and corresponding author of this study, confirmed for Medical News Today that the participants were taking Mounjaro as an off-label treatment for weight management at the discretion of their prescribing physician. During their study, researchers also reported that about 32% of participants who started tirzepatide had class 3 obesity with a BMI of 40 kg/m 2 or more
This happens because the active ingredient, guaifenesin, can sometimes irritate the lining of your stomach
Identifying danger symptoms, such as intense abdominal pain, jaundice, or dyspnea, can assist individuals in responding swiftly
Morning dosing kept the highest signal during the day